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Abstract Artemisinin is a potent antimalarial drug; however,
it suffers from unstable and insufficient supply from plant
source. Here, we established a novel multivariate-modular
approach based on experimental design for systematic path-
way optimization that succeeded in improving the production
of amorphadiene (AD), the precursor of artemisinin, in
Escherichia coli. It was initially found that the AD production
was limited by the imbalance of glyceraldehyde 3-phosphate
(GAP) and pyruvate (PYR), the two precursors of the 1-de-
oxy-D-xylulose-5-phosphate (DXP) pathway. Furthermore, it
was identified that GAP and PYR could be balanced by re-
placing the phosphoenolpyruvate (PEP)-dependent phospho-
transferase system (PTS) with the ATP-dependent galactose
permease and glucose kinase system (GGS) and this resulted
in fivefold increase in AD titer (11 to 60 mg/L). Subsequently,
the experimental design-aided systematic pathway optimiza-
tion (EDASPO) method was applied to systematically opti-
mize the transcriptional expressions of eight critical genes in
the glucose uptake and the DXP and AD synthesis pathways.
These genes were classified into four modules and simulta-
neously controlled by T7 promoter or its variants. A regres-
sionmodel was generated using the four-module experimental
data and predicted the optimal expression ratios among these
modules, resulting in another threefold increase in AD titer
(60 to 201 mg/L). This EDASPO method may be useful for
the optimization of other pathways and products beyond the
scope of this study.
Keywords Amorphadiene . Experimental design-aided
systematic pathway optimization .Multivariate-modular
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Introduction
In Escherichia coli and other bacteria, isoprenoids are synthe-
sized through the 1-deoxy-D-xylulose-5-phosphate (DXP)
pathway originating from two precursors (pyruvate (PYR)
and glyceraldehyde 3-phosphate (GAP)). As equal amounts
of two precursors are optimal for the DXP pathway, the im-
balance of the two precursors could reduce the biosynthesis of
isoprenoids. The conversion from G3P to pyruvate involves
three reversible enzymatic steps and one essentially irrevers-
ible step (between phosphoenolpyruvate (PEP) and PYR,
Fig. 1) (Farmer and Liao 2001). And it was reported that
redirection of metabolic flux from PYR to PEP by the over-
expression of the gluconeogenic enzyme, PEP synthetase
(ppsA), enhanced lycopene yield (Farmer and Liao 2000;
Farmer and Liao 2001). The results indicate that it is possible
to balance the G3P and PYR through the manipulation of the
ratio between PEP and PYR, and redirection of metabolic flux
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from PYR to GAP is beneficial for isoprenoid production.
Similarly, inactivation of the carbohydrate phosphotransferase
system (PTS) can also increase the ratio between PEP and
PYR (Chatterjee et al. 2001; Flores et al. 1996; Zhang et al.
2009b), thus is potentially applicable to enhance isoprenoid
biosynthesis in E. coli.
The phosphotransferase system (PTS) is composed of en-
zyme I (EI), histidine protein (HPr), sugar-specific enzyme
IIA (EIIA), and enzyme IICB (EIICB), encoded by gene
ptsHIcrr operon and ptsG, respectively. The PTS is the major
glucose uptake pathway in E. coli, and half of the PEP pro-
duced from glucose is metabolized into PYR during the glu-
cose uptake by the PTS (Gorke and Stulke 2008). Thus, the
deletion of the PTS can increase the intracellular PEP/PYR
ratio and thus increase the intracellular GAP/PYR ratio.
However, the disruption of the PTS resulted in the decreased
glucose uptake rate and significantly impeded cell growth
(Martínez et al. 2008). To address this issue, adaptive evolu-
tion was used to select fast-growing strains (Flores et al.
1996). Transcriptome analysis in these fast-growing strains
indicated that the expressions of gene galP (coding for galac-
tose permease), glk (coding for glucose kinase), and pgi (cod-
ing for phosphoglucose isomerase) were increased as com-
pared to the wild-type strain, suggesting that these genes were
important in enhancing glucose uptake (Flores et al. 2007;
Flores et al. 2002). Hence, it was reported that the overexpres-
sion of galP and glk enhanced the growth rate of microbes in
glucose medium (Flores et al. 2007; Lu et al. 2012) and im-
proved the yields of valuable products such as aromatics (Yi
et al. 2003), recombinant protein (De Anda et al. 2006), and
ethanol (Hernandez-Montalvo et al. 2003). Combinatorial
modulation of galP and glk gene expressions has been used
to improve cell growth rate (Lu et al. 2012), but it is unclear if
such an approach will increase the production of isoprenoids.
Fig. 1 Global control and balance of metabolic pathways for AD
production. T7, TM1, TM2, and TM3 promoters were used to fine
control the expression of the four different modules (galP-glk, dxs,
ispDF-idi or idi, and ispA-ADS). The metabolites in the figure were as
follows: glucose (GLC), glucose-6-phosphate (G6P), glyceraldehyde 3-
phosphate (GAP), phosphoenolpyruvate (PEP), pyruvate (PYR), 1-
deoxy-D-xylulose 5-phosphate (DXP), 2C-methyl-D-erythritol 4-
phosphate (MEP), 4-diphosphocytidyl-2C-methyl-D-erythritol
(CDPME), 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate
(CDPMEP), 2C-methyl-D-erythritol 2,4-diphosphate (MEC),
hydroxylmethylbutenyl diphosphate (HMBPP), isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), geranyl
diphosphate (GPP), farnesyl pyrophosphate (FPP), and amorpha-4,11-
diene (AD). The enzyme-coding genes in the figure were as follows:
PTS enzyme IIBC (ptsG), histidine protein (ptsH), PTS enzyme I (ptsI),
PTS enzyme IIA(crr), galactose permease (galP), glucose kinase (glk),
phosphoenolpyruvate synthetase (ppsA), DXP synthase (dxs), DXP
reductase (dxr), CDPME synthase (ispD), CDPME kinase (ispE),
CDPMEP synthase (ispF), HMBPP synthase (ispG), HMBPP reductase
(ispH), IPP isomerase (idi), FPP synthase (ispA), and AD synthase (ADS)
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Pathway optimization by modulating the activities and ex-
pressions of enzymes in the pathway is critical for improving
product yields. Optimized pathways can minimize the accu-
mulation of intermediate metabolites with potential cytotoxic-
ity and thus decrease the metabolic burdens and increase the
final product titers (Anthony et al. 2009; Pfleger et al. 2006).
Multivariate-modular approach to balance metabolic pathway
has been successfully used to systematically search for the
optimal conditions for taxadiene production, resulting in 15,
000-fold increase in taxadiene titer over the control (Ajikumar
et al. 2010). Modulating plasmid copy numbers or engineer-
ing different types of promoters (Jones et al. 2000) has been
used to control and balance the expression levels of multiple
genes for more than 10 years. However, these approaches are
time consuming and resource demanding and may not cover a
sufficiently broad search space to allow the identification of
conditions for optimal productivity.
In this study, the hypothesis that amorphadiene (AD)
production from glucose can be improved by enhancing
the availability of GAP through PEP was tested. By de-
leting the PTS and overexpressing the ATP-dependent ga-
lactose permease and glucose kinase system (GGS), the
AD production was significantly increased by fivefold.
Optimization of the production of AD was then carried
out by experimental design-aided systematic pathway opti-
mization (EDASPO) to globally regulate four distinct
modules (including eight critical genes in the glucose up-
take and the DXP and AD synthesis pathways) with small
number of experiments. Using T7 promoter variants with
different transcriptional efficiencies to control multiple
modules simultaneously (Too et al. 2014), EDASPO meth-
od enables the rapid discovery of the optimal conditions
for high productivity with a small number of experiments.
Based on the relative transcriptional efficiencies of T7
promoter and its variants, regression analysis of the four-
module data predicted the optimal expression ranges for
each module to further increase AD production. And the
prediction was validated experimentally, resulting in anoth-
er threefold enhancement in AD titer.
Materials and methods
Bacterium strains and plasmids
E. coli K12 MG1655 ΔrecAΔendA DE3 was used as the
parental strain (Ajikumar et al. 2010). MG1655 ΔPTS::FRT
(PTS- for short) strain was obtained by replacing operon
ptsHIcrr with a kanamycin-resistant gene using the λ Red
recombination system (Zhang et al. 2013). And the
kanamycin-resistant gene was subsequently excised by the
Flp/FRT site-specific recombination system (Datsenko
2000). Chromosomal deletions were verified by testing for
antibiotic markers and colony PCR analysis.
Plasmid pET-galP-glk was constructed from three
parts, pETaa vector, gene galP, and gene glk, by
cross-lapping in vitro assembly (CLIVA) method using
I-pETR(galPF), I-galPF(pETR), I-galPR(glkF), I-
g lkF(ga lPR) , I -pETF(glkR) , and I -g lkR(pETF)
(Table 1) (Zou et al. 2013). Plasmids pETA-TM1/2/3-
galP-glk were constructed from pET-galP-glk by mutat-
ing T7 promoter to TM1/TM2/TM3 promoter using the
oligo TM1, TM2, and TM3 (Table 1). Plasmid p15A-
spec-T7-ppsA was constructed from two parts, 15A-spec
vector and ppsA gene, by CLIVA method using I-
ppsA(t7pr)-F, I-ppsA(t7tf)-R, I-T7P(-)-R, and I-T7T(-)-F
(Table 1).
All the information about the strains, plasmids, and primers
is in Tables 1 and 2.
Construction of the four-module expression system
The four modules were controlled simultaneously under
T7 and T7 variant promoters with different transcrip-
tional efficiencies (TM1, TM2, and TM3; the transcrip-
tional efficiencies of TM1, TM2, and TM3 were 92, 37,
and 16 % of that of T7 promoter, respectively). TM1,
TM2, and TM3 promoters were generated as described
in the patent (Table 1) (Too et al. 2014). A portion of
combinations was chosen based on the principles of
experimental design and a priori knowledge about
three-module (dxs, ispDF-idi, ispA-ADS) optimization
results. In the three-module experiments, the construct
231 (where the three modules dxs, ispDF-idi, and
ispA-ADS were controlled by TM2, TM3, and TM1 pro-
moters, respectively) and the construct 332 (where the
three modules dxs, ispDF-idi, and ispA-ADS were con-
trolled by TM3, TM3, and TM2 promoters, respective-
ly) produced the highest titers of AD and thus were
included in this experiment. To cover a broad range,
each module was controlled by three different promoters
(TM1, TM2, and TM3). Each promoter for each module
was repeated at least three times (for example, TM1 for
the first module was used in four constructs, P1231,
P1332, P1121, and P1313). As a result, 14 construct
were chosen and tested with four different concentra-
tions of isopropyl β-D-1-thiogalactopyranoside (IPTG)
(Table 3).
Media and culture conditions
Defined media composition
The defined media without carbon contained 4 g/L
(NH4)2HPO4, 3.50 g/L KH2PO4 and 9.28 g/L K2HPO4,
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1.7 g/L citric acid, 0.5 g/L MgSO4, 2.5 mg/L CoCl2·
6H2O, 15.0 mg/L MnSO4·4H2O, 1.5 mg/L CuSO4·
2H2O, 3 mg/L H3BO3, 2.5 mg/L Na2MoO4·2H2O,
13 mg/L Zn(CH3COO)2, 60 mg/L Fe(III) citrate, and
8.4 mg/L EDTA. Glucose (20 g/L) was added into the
defined media before use.
Table 1 Strains, plasmids, and primers used in this study
Strains/plasmids/primers Description/sequence References
Strains
MG1655 DE3 E. coli K12 MG1655ΔrecAΔendA DE3 (Ajikumar et al. 2010)
MG1655 DE3 ΔPTS::FRT MG1655 DE3 derived, ΔpstHIcrr::FRT This study
Plasmids
p15A-spec-T7-ppsA pAC-LYC derived (Cunningham et al. 1994) by replacing crtEBI with ppsA
under the control of T7 promoter and replacing chloramphenicol-resistant
gene with spectinomycin-resistant gene
This study
pETA-galP-glk pET-11a (Novagen) derived, galP-glk operon under the control of T7
promoter
This study
pETA-TM1-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM1 promoter This study
pETA-TM2-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM2 promoter This study
pETA-TM3-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM3 promoter This study
pBAD-galP-glk pBAD-B (Invitrogen) derived, galP-glk operon was placed under the
control araBAD promoter
This study
pACM-T7-dxs-T7-idi-T7-ADS-ispA pAC-LYC derived, dxs-idi-ADS-ispA operon was placed under the
control of T7 promoter
This study
pACM-T7-dxs-idi-ispDF-T7-ADS-ispA pAC-LYC derived, dxs-idi-ispDF-ADS-ispA operon was placed under the
control of T7 promoter
This study
pETK-lacI pET-11a derived, ampicillin-resistant gene was replaced with kanamycin-
resistant gene using CLIVA
This study
pACM-TM2-dxs-TM3-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the
control of TM2, TM3, and TM1 promoters, respectively
(Too et al. 2014)
pACM-TM3-dxs-TM3-idi-ispDF-TM2-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the
control of TM3, TM3, and TM2 promoters, respectively
(Too et al. 2014)
pACM-TM1-dxs-TM2-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under
the control of TM1, TM2, and TM1 promoters, respectively
(Too et al. 2014)
pACM-TM1-dxs-TM1-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under
the control of TM1, TM1, and TM1 promoters, respectively
(Too et al. 2014)
pACM-TM3-dxs-TM1-idi-ispDF-TM3-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under
the control of TM3, TM1, and TM3 promoters, respectively
(Too et al. 2014)
Primers
TM1 promoter TAATACGACTCACTAATGGGGA This study
TM2 promoter TAATACGACTCACTCGAGGGGA This study
TM3 promoter TAATACGACTCACTATAGAAGA This study
I-pETR(galPF) AGCGTCAGGCATA*TGTATATCTCCTTC*TTAAAGTT This study
I-galPF(pETR) AAGGAGATATA*CATATGCCTGACGCT*AAAAAAC This study
I-galPR(glkF) GATCTGCCTCCT*TTAATCGTGAGCG*CCTA This study
I-glkF(galPR) CGCTCACGATTA*AAGGAGGCAGATC*AAATGACAAAG
TATGCATTAGTC
This study
I-pETF(glkR) GGTCACATTCT*GTAAAAGCTGAGTTGGC*TGC This study
I-glkR(pETF) GCCAACTCAGCTT*TTACAGAATGTGACC*TAAGG This study
I-gg-F(pBADR) ATTAACCA*TGCCTG*ACGCTAAAAAAC This study
I-gg-R(pBADF) AACAGCCT*TACAGA*ATGTGACCTAAGG This study
I-pBAD-F(ggR) TCTGTAAG*GCTGTT*TTGGCGGATGAG This study
I-pBAD-R(ggF) CAGGCATG*GTTAAT*TCCTCCTGTTAGCCC This study
I-ppsA(t7pr)-F CCCTCTAGAA*ATAATTTTGTT*TTTCTCAAACCGTTCATTTA This study
I-ppsA(t7tf)-R CCAACTCA*GCTTCCTTT*AACGCAGGATGTCTGTGAA This study
I-T7P(-)-R AACAAAATTATT*TCTAGAGGG*GAA This study
I-T7T(-)-F AAAGGAAG*CTGAGTTGG*CTG This study
The asterisked oligos were phosphorothioate-modified oligos used for CLIVA cloning (Zou et al. 2013)
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All the amorpha-4,11-diene titers reported here were based
on the strains grown in the defined media supplemented with
20 g/L glucose.
2xpy medium composition
The 2xpy medium contained 20 g/L peptone, 10 g/L yeast
extract, and 10 g/L NaCl. The medium was adjusted to pH
7.0 and autoclaved at 121 °C for 20 min.
Culture conditions
New transformed strains were rescued and grown in
2xpy medium overnight, and 1 % (v/v) overnight grown
cell culture was inoculated into 1 mL defined media in
a 14-mL BD Falcon™ tube. Dodecane with 100 mg/L
beta-caryophyllene was added to 20 % (v/v) of the me-
dium volume. Cells were grown at 28 °C with 300 rpm
shaking speed and induced with different dosages of
IPTG when OD600 reached the range of 0.5~1.0. The
media were supplemented with 100 mg/L ampicillin,
34 mg/L chloramphenicol, 50 mg/L kanamycin, and
100 mg/L spectinomycin to maintain the pET-11a-
derived plasmids, pAC-LYC-derived plasmids, pETK-
lacI, and p15A-spec-T7-ppsA, respectively.
AD quantification
AD was extracted by diluting 5 μL dodecane phase into
495 μL ethyl acetate and analyzed on an Agilent 7980A gas
chromatograph equipped with an Agilent 5975C mass spec-
trometer (GC/MS). Beta-caryophyllene (Sigma-Aldrich) was
used as an equivalent, and the GC-MS condition was set as the
method reported by scanning for only two ions (204 and 189
m/z ion) (Tsuruta et al. 2009).
Calculation of relative expression of each module
Relative expression level of eachmodule was calculated based
on the promoter transcriptional efficiencies and plasmid copy
numbers. It is calculated using the following equation.
Ei Cð Þ ¼ Mi  Ni
X4
j¼1
M j  N j
where Ei is the relative expression level of the module i in the
construct C, Mi is the promoter transcriptional efficiency of
module i, and Ni is the plasmid copy number of module i.
For example, the transcriptional efficiencies of TM1, TM2,
and TM3 were 92, 37, and 16 % of that of T7 promoter,
Table 2 Name list of strains carrying different plasmids in this study
Strains Plasmids Short name Reference
MG1655 DE3 ΔPTS::FRT pETA-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA PGG This study
MG1655 DE3 pETA-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA MGG This study
sMG1655 DE3 pETK-lacI and pACM-T7-dxs-T7-idi-ADS-ispA MGG01 This study
MG1655 DE3 p15A-spec-T7-ppsA, pETK-lacI and pACM-T7-dxs-T7-idi-ADS-ispA MGG02 This study
MG1655 DE3 ΔPTS::FRT pETA-TM1-galP-glk and pACM-TM2-dxs-TM3-idi-ispDF-TM1-ADS P1231 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-TM2-dxs-TM3-idi-ispDF-TM1-ADS P2231 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-TM2-dxs-TM3-idi-ispDF-TM1-ADS P3231 This study
MG1655 DE3 ΔPTS::FRT pETA-TM1-galP-glk and pACM-TM3-dxs-TM3-idi-ispDF-TM2-ADS P1332 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-TM3-dxs-TM3-idi-ispDF-TM2-ADS P2332 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-TM3-dxs-TM3-idi-ispDF-TM2-ADS P3332 This study
MG1655 DE3 ΔPTS::FRT pETA-TM1-galP-glk and pACM-TM1-dxs-TM2-idi-ispDF-TM1-ADS P1121 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-TM1-dxs-TM2-idi-ispDF-TM1-ADS P2121 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-TM1-dxs-TM2-idi-ispDF-TM1-ADS P3121 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-TM1-dxs-TM1-idi-ispDF-TM1-ADS P2111 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-TM1-dxs-TM1-idi-ispDF-TM1-ADS P3111 This study
MG1655 DE3 ΔPTS::FRT pETA-TM1-galP-glk and pACM-TM3-dxs-TM1-idi-ispDF-TM3-ADS P1313 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-TM3-dxs-TM1-idi-ispDF-TM3-ADS P2313 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-TM3-dxs-TM1-idi-ispDF-TM3-ADS P3313 This study
MG1655 DE3 ΔPTS::FRT pETA-TM1-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P1000 This study
MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P2000 This study
MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P3000 This study
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respectively; the first module was in the pAC-derived
vector (p15a origin) with around ten copies, and the
other three modules were in the pET-derived vector
(pBR322 origin) with about 30 copies. Therefore, the
relative expression level of the first module (galP-glk)
in strain P1231 was
E1 P1231ð Þ ¼ 92 %  1092 %  10 þ 37 % þ 16 % þ 92 %ð Þ  30 ¼ 0:17
Results
Overexpression of ppsA increased AD production
In this study, the native DXP pathway in E. coli was used to
produce AD (Fig. 1). The DXP pathway starts from PYR to
GAP. PYR is abundant inside the cells and known to be
exported out of the cells (Kreth et al. 2013), and the redirection
of metabolic flux from PYR to GAP by the overexpression of
PEP synthetase (ppsA) has been shown to enhance lycopene
yield (Farmer and Liao 2000). To test the hypothesis that the
overexpression of ppsA can similarly enhance the production
of another isoprenoid, AD, cells were transformed with a plas-
mid encoding the endogenous ppsA gene under the control of
the T7 promoter. As high expression of ppsA is toxic and
negatively affects the growth of E. coli (Farmer and Liao
2000; Patnaik et al. 1992), the expression of ppsAwas mod-
erately induced at levels that did not significantly affect cell
growth (Fig. 2b). As shown in Fig. 2, the AD titer (mg/L) and
specific yield (mg/L/OD) increased to about twofold when
ppsA was overexpressed in all the conditions examined (dif-
ferent concentrations of IPTG). The result was consistent with
the hypothesis that increasing the availability of GAP through
increasing the intracellular PEP (Fig. 1) would increase AD
production, albeit modestly.
Overexpression of galP and glk increased AD production
Similar to the ppsA overexpression, the PTS knockout can
also increase the intracellular PEP. As glucose uptake via the
PTS is known to consume half of PEP produced from glucose
and produces PYR (Hernandez-Montalvo et al. 2003), an at-
tempt was made to use an alternative pathway for the cells to
import glucose. Unlike the PTS which uses PEP as phosphate
donor, the GGS transports and phosphorylates glucose using
ATP as phosphate donor, thus increasing intracellular PEP and
increasing the availability of intracellular GAP. As shown in
Fig. 3, overexpression of the GGS in the wild type using T7
promoter (The resulting strain was named as MGG, Table 2)
resulted in an increase in AD titer (mg/L) by more than three-
fold (from 10 to 37 mg/L) as compared to wild type (MGG01,
Table 2). With the PTS deletion and the overexpression of the
GGS, AD titer (The resulting strain was named as PGG,
Table 2) was further increased by 70 % to ~60 mg/L as com-
pared to that ofMGG. The specific yield of AD increased from
about 7mg/L/OD (MGG) to ~12mg/L/OD (PGG). The results
indicated that the glucose uptake pathway played a significant
part in the AD production where the ATP-dependent GGS
(PGG strain, Table 2) was superior to the PEP-dependent
PTS (MGG01 strain, Table 2). Noteworthy, the cell density
was similar for the three strains in most of the conditions
except that the cell density of MGG and PGG was very low
when high concentration of inducer was used. This suggested
that the high expression of the GGS could be toxic to cells.
Differential control of multivariant modules encoding critical
enzymes in the glucose uptake and the DXP and AD synthesis
pathways
A two-module optimization of the upstream DXP pathway and
heterologous downstream terpenoid-forming pathway in-
creased Taxol precursor titer significantly (Ajikumar et al.
2010). As the replacement of the PTS with the GGS increased
AD yield, we hypothesized that the global pathway optimiza-
tion of the GGS and the DXP and AD synthesis pathways
could further increase AD production. It was reported that over-
expression of dxs, ispDF, and idi improved the yields of carot-
enoids (Alper et al. 2005; Yuan et al. 2006) and taxol precursor
(Ajikumar et al. 2010). In addition, ADS has been identified as
a critical step for the AD production (Anthony et al. 2009;
Pitera et al. 2007). All these important enzymes and glucose
uptake transporters were grouped into four modules. The first
module encoded galP-glk, which regulates glucose uptake. The
second module encoded dxs, which diverts the carbon flux
from central metabolic pathway into the DXP pathway. The
operon ispDF-idi was encoded in the third module where
ispDF facilitates the conversion of intermediates of the DXP
pathway and idi is crucial for balancing the ratio of isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP).
Lastly, ispA and ADS genes were encoded in the fourth module
where enzyme ispA condensates IPP and DMAPP into FPP
and FPP is cyclized into AD by enzyme ADS (Fig. 1).
All the four modules were controlled simultaneously under
the native T7 promoter or its variants (TM1, TM2, and TM3)
in a combinatorial manner. As a result, the total combination
of four-module system with four different promoters has 44=
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256 constructs. To limit the number of conditions to be tested,
14 constructs (Fig. 4d) were analyzed based on the experimen-
tal design principle (the details about these constructs were
explained in BMaterials and methods^). As shown in Fig. 4,
through the differential control of the four modules, AD titer
varied significantly by more than 190-fold from 0.36 mg/L
(strain P1313 with 0.03 mM IPTG) to 68.9 mg/L (strain
P2121 with 0.01 mM IPTG).
Regression analysis of the four-module expression system
To identify the global optimal condition and to gain an insight
into the behavior of the four-module expression system, a
linear regression model was used to analyze the experimental
data in Fig. 4. The relative expression of each module
(Table 3) was calculated from the transcriptional efficiencies
of promoters and copy numbers of plasmids, as described in
BMaterials and methods^. As the relative expression of each
module is independent of the inducer dosage, the averages of
AD titers at different inducer dosages were used in the regres-
sion analysis. The experimental data and regression model
were shown in three-dimensional figures for each two mod-
ules (Fig. S1). For the ease of visualization and analyses, the
data were also demonstrated as two-dimensional heat maps
for each two modules using a linear regression model
(Fig. 5). Based on the analyses, the optimal ranges for the four
modules were well accounted by the 14 chosen constructs.
The predicted optimal ranges of relative expression levels of
the four modules (galP-glk, dxs, ispDF-idi, and ispA-ADS)
were 0.04~0.1, 0.25~0.4, 0.1~0.4, and 0.25~0.44, respective-
ly. Thus, a relatively lower expression of the first module
(galP-glk) was found to be beneficial for AD production.
Higher expression levels of the second (dxs) and the fourth
modules (ispA-ADS) were required. Interestingly, for the third
module (ispDF-idi), both low expression (~0.15) and high
expression (~0.35) resulted in higher AD production.
Especially in Fig. 5b, there were two optimal ranges for the
third module (ispDF-idi) when the relative expression level of
the first module (galP-glk) is within 0.04~0.1. Further studies
demonstrated the operon ispDF in the third module was less
important and may even be adverse for AD production in
certain conditions (Fig. S2).
Further improvement of AD production facilitated
by regression analysis
From the regression analysis of four-module expression sys-
tem data, we concluded that the first module encoding galP-
glk was beneficial when expressed at a relatively lower level;
modules encoding dxs and ispA-ADS were required to be
expressed at relatively higher levels, and the expression of
ispDF in third module was unnecessary. Thus, we constructed
strains where the genes dxs, idi, and the operon ispA-ADS
were under the control of the native T7 promoter, and the
operon galP-glk was controlled by TM1, TM2, or TM3 pro-
moter (Fig. 1, the details of the three strains were shown in
Table 2). The relative expression levels of the fourmodules for
the three strains were shown in Table 4. As a result, the highest
AD titer in strain P2000 increased by ~3-fold when compared
to that of P2121, an increase from 68.9 to 201.2 mg/L (Fig. 6).
In addition, the specific yield was also enhanced significantly
from ~12.2 to ~18.0 mg/L/OD, validating the prediction from
regression analysis. Interestingly, similar to other 14 strains of
the four-module expression systems, the cell density of strain
P1000, P2000, and P3000 was inversely correlated with the
inducer dosages (Fig. 6b).
Discussion
In E. coli, isoprenoid biosynthesis is reported to be limited by
imbalance of GAP and PYR, or specifically, the GAP is less
abundant than the PYR. As PEP and GAP are interconvertible
with three reversible enzymatic reactions, the overexpression
of ppsA (catalyzing PYR to PEP) or pck (converting oxaloac-
etate to PEP) can increase the availability of intracellular GAP
by increasing intracellular PEP and thus enhanced the produc-
tion of lycopene (a C40 isoprenoid) (Farmer and Liao 2000;
Farmer and Liao 2001). Similarly, the AD production was
Table 3 Relative expression levels of each module in the 14 constructs
of four-module expression system
No. Strainsa Relative expression levels of each module
galP-glk dxs ispDF-idi ispA-ADS
1 P1231 0.17 0.21 0.09 0.52
2 P2231 0.08 0.24 0.10 0.58
3 P3231 0.04 0.25 0.11 0.61
4 P1332 0.31 0.16 0.16 0.37
5 P2332 0.15 0.20 0.20 0.45
6 P3332 0.07 0.22 0.22 0.50
7 P1121 0.12 0.37 0.15 0.37
8 P2121 0.05 0.39 0.16 0.39
9 P3121 0.02 0.41 0.16 0.41
10 P2111 0.04 0.32 0.32 0.32
11 P3111 0.02 0.33 0.33 0.33
12 P1313 0.20 0.10 0.59 0.10
13 P2313 0.09 0.12 0.67 0.12
14 P3313 0.04 0.12 0.71 0.12
a The strains were named based on their sequence of promoters; numbers
B1,^ B2,^ and B3^ stood for TM1, TM2, and TM3 promoters, respectively
(e.g., P1231 referred to a construct in which galP-glk, dxs, idi, and ispA-
ADS were controlled by TM1, TM2, TM3, and TM1 promoters,
respectively)
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Fig. 2 Overexpression of ppsA increasedADproduction. aAD titer (mg/
L). b Cell density of different strains. c Specific yield of AD (mg/L/DO).
OD optical density of culture at 600 nm. MGG01 strain was the control
strain without overexpressing ppsA, whereas ppsAwas overexpressed in
MGG02 strain
Fig. 3 The effect of different glucose uptake pathways (the GGS and/or
the PTS) on AD production. MGG01was the wild-type strain which used
the PTS to import glucose. MGG was the wild-type strain with the GGS
overexpressed which used both the PTS and the GGS to import the
glucose, and PGG was the PTS knockout mutant with the GGS
overexpressed; thus, the glucose was imported solely by the GGS
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predictably increased when ppsA was overexpressed, indica-
tive of the importance of balancing GAP and PYR (Fig. 2).
This inspired us to explore the productivity of the PTS knock-
out strain, as inactivating the PTS can increase intracellular
PEP and thus may increase intracellular GAP. Thus, it was
hypothesized that the deletion of the PTS could potentially
redirect more carbon flux from the central pathway to the
synthesis of isoprenoids through the DXP pathway. In
E. coli, the PTS is the main glucose transport system and is
also responsible for carbon catabolite repression (CCR) and
chemotaxis (Hernandez-Montalvo et al. 2003). Thus, deletion
of the PTS is also pleiotropic and its mutant has several dis-
tinct characteristics over the wild-type strain, such as enhance-
ment of intracellular PEP concentration, coexistence of glyco-
lytic and gluconeogenic pathways, and the simultaneous uti-
lization of different carbon sources (Flores et al. 2002). The
PTS mutant is able to co-utilize xylose and glucose (Nichols
et al. 2001) and produces higher titers of various compounds
such as recombinant proteins (Chou et al. 1994), aromatics
(Flores et al. 1996), lysine (Lindner et al. 2011), L-phenylala-
nine (Baez-Viveros et al. 2007), and succinate (Zhang et al.
2009b). However, the uptake rate of glucose in PTS mutant is
known to be low (Flores et al. 2007; Flores et al. 2002) and
consequently the growth rate is exceptionally low. Therefore,
in this study, the GGS was overexpressed in the PTS-deficient
mutant in an attempt to increase the biomass when grown on
glucose.
As predicted, the use of the GGS (consuming ATP) to
increase glucose uptake in the PTS-deficient mutant was
found to be beneficial for AD production (Fig. 3).
Considering the benefit of using the GGS glucose uptake
pathway, we hypothesized that global pathway balancing of
the glucose uptake and the DXP and AD synthesis pathways
may further improve the AD production. Although AD titer
varied more than 190-fold within different conditions, the best
construct (P2121) only improvedAD titer by 15% than that of
Fig. 4 Optimization of AD production by simultaneously controlling
four modules. TM1, TM2, and TM3 promoters were used to control the
expression of the four modules: galP-glk, dxs, ispDF-idi, and ispA-ADS.
The strains were named based on their sequence of promoters, and
numbers 1, 2, and 3 stood for TM1, TM2, and TM3 promoters,
respectively, e.g., P1231 referred to a construct in which the four
modules galP-glk, dxs, ispDF-idi and ispA-ADS were under the control
of TM1, TM2, TM3, and TM1 promoters, respectively. The
transcriptional efficiencies of TM1, TM2, and TM3 were 92, 37, and
16 % of that of T7 promoter, respectively. a AD titer (mg/L). b Cell
density of different strains. c Specific yield of AD (mg/L/DO). d
Illustration of different constructs (the thickness of arrows represented
the relative transcriptional efficiencies of promoters)
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PGG strain. And it was also observed that high expressions of
the GGS improved specific yield of AD but inhibited cell
growth in PGG and MGG (Fig. 3) and the 14 strains of the
four-module expression system (Fig. 4). The decreased cell
density at high induction level is likely to be due to the stress
of high expression of galactose permease and glucose kinase
(Lu et al. 2012) or sugar phosphate stress due to accumulation
of glucose-6-phosphate or fructose-6-phosphate (Morita et al.
2003), and this requires further investigation. Nevertheless,
this limitation can be mitigated with tight control of the
expressions of galP and glk using the combinatorial modular
expression system described herein.
To better understand the behavior of the four-module ex-
pression system, the experimental data were analyzed using a
linear regression model. Based on the regression analysis
(Fig. 5), the optimal ranges of expression levels for the first,
second, and fourth modules were identified using the panel of
constructs. However, the third module was predicted to have
multiple optimal ranges (~0.15 and ~0.35). Further experi-
ment indicated that excluding ispDF resulted in a slightly
enhanced AD production as compared to the inclusion of
ispDF in our conditions (Fig. S2). This finding was consistent
with previous reports that enhancement in production of var-
ious metabolites requires only dxs and idi but not ispDF to be
overexpressed or modulated (Jin and Stephanopoulos 2007;
Morrone et al. 2010; Sun et al. 2014) and that the overexpres-
sion of ispDF operon even decreased isoprenoid production
(Zou et al. 2013). The enzymes ispD and ispFwere reported to
be more soluble than the enzymes dxs and idi and may have
higher activities (Zhou et al. 2012); hence, the overexpression
of ispDF may be unnecessary when the pathway was opti-
mized, and further study is required to address this issue.
The fourth module was required to be expressed at higher
levels as the activity of heterologous ADS from Artemisia
annua is known to be poor in E. coli (Chen et al. 2013;
Green et al. 2009). Consistent with the prediction of the
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Fig. 5 Regression analysis of the four-module expression system. The
regression of AD titers on the relative expression levels of every two
modules (a galP-glk and dxs; b galP-glk and ispDF-idi; c galP-glk and
ispA-ADS; d dxs and ispDF-idi; e dxs and ispA-ADS; f ispDF-idi and
ispA-ADS). Both abscissa and ordinate referred to the relative
expressional levels of their modules. Relative expression levels were
calculated based on the promoter transcriptional efficiencies and plasmid
copy numbers (as described in BMaterials and methods^). Blue dots in the
figures were experimental data as consistent with Fig. S1
Table 4 Relative expression levels of each module in constructs
P1000, P2000, and P3000
No. Strainsa Relative expression levels of each module
galP-glk dxs idi ispA-ADS
1 P1000 0.09 0.30 0.30 0.30
2 P2000 0.04 0.32 0.32 0.32
3 P3000 0.02 0.33 0.33 0.33
a The strains were named based on their sequence of promoters; number
B0,^ B1,^ B2,^ and B3^ stood for T7, TM1, TM2, and TM3 promoters,
respectively (e.g., P1000 referred to a construct in which galP-glk, dxs,
idi, and ispA-ADS were controlled by TM1, T7, T7, and T7 promoters,
respectively)
3834 Appl Microbiol Biotechnol (2015) 99:3825–3837
regression model, the combination of a relatively lower ex-
pression of galP-glk and higher expression of dxs and ispA-
ADS enhanced AD production. These predictions were vali-
dated experimentally using strains P1000, P2000, and P3000
where AD titer increased another threefold as compared to the
highest titer in the 14 constructs (overall ~19-fold increase
over that of wild type). To our knowledge, this was the first
study that simultaneously controlled four expression modules.
These results demonstrated the successful application of
EDASPO for the pathway optimization, especially whenmore
than three modules were involved. And the major advantage
of EDASPO lies in its predictability with a small portion of the
full combination; thus, it significantly decreases the time cost
and the work amount.
In this study, a chemically defined medium (CDM), instead
of complex media (CM), was used to produce AD. It was
worth noting that the 20 g/L glucose added into the CDM
wasmore than enough (other nutrition was limiting), and there
was glucose left in the media (data not shown) when the AD
was harvested for all the experiments. In most cases, CDMhas
a relatively low production unless through extensive medium
optimization. However, CDM has a few advantages. For ex-
ample, CDM is more cost-effective as CM ingredients (such
as yeast extract, tryptone, and peptone) are much more expen-
sive than inorganic nitrogen salts (such as ammonium salts or
ammonia). Furthermore, unlike CM whose composition
varies with batches and suppliers, CDM is more reliable and
scalable, making it a preferred medium for fed-batch high-cell
density cultivations (Li et al. 2014). In addition, the compli-
cated interactions among complex components in CM may
interfere with the pathway optimization and kinetic study, thus
making data more difficult to interpret (Zhang et al. 2009a). It
is interesting to note that the AD yield (18mg/L/OD) using the
DXP pathway was among some of the highest yields reported
to date (Zhang et al. 2013; Zhou et al. 2013). However, as
compared to the highest AD yield using the mevalonate
(MVA) pathway in Saccharomyces cerevisiae (242 mg/L/
OD) (Westfall et al. 2012), our yield was ~13-fold lower.
Preliminary study of optimizing the MVA pathway using
EDASPO resulted in a comparable AD yield of more than
200 mg/L/OD in E. coli (unpublished observation), demon-
strating the broader utility of this approach.
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